期刊文献+

中国北方地区汉族人冠心病患者血清胆固醇酯转运蛋白的水平 被引量:3

Serum Cholesteryl Ester Transfer Protein Levels in Patients with Coronary Heart Disease in Han Nationality from Northern China
暂未订购
导出
摘要 为分析冠心病患者血清胆固醇酯转运蛋白的水平 ,采用病例—对照研究胆固醇酯转运蛋白与血脂、脂蛋白和载脂蛋白水平的相关性。应用酶联免疫吸附试验测定 10 6例冠心病患者和 6 4例正常对照者血清胆固醇酯转运蛋白浓度 ,结果分别为 2 .15± 0 .90mg L和 2 .31± 1.0 8mg L ,两者差异无显著性 (P >0 .0 5 )。相关分析显示 ,血清胆固醇酯转运蛋白浓度与其他血脂和脂蛋白水平无显著相关性 (P >0 .0 5 )。以上提示 ,血清胆固醇酯转运蛋白水平不是中国北方地区汉族人冠心病发生的主要危险因素。 Aim To determine the serum cholesteryl ester transfer protein(CETP) level in patients with coronary heart disease(CHD) in Han nationality and explore its association with serum lipids, lipoproteins and apolipoproteins levels. Methods To undertake a case control study, we detected the serum CETP level in 64 unrelated healthy individuals and 106 patients with evidence of CHD by enzyme linked immunosorbent assay. Results The results showed that there was not statistically different between patients and controls(2.15±0.90 mg/L vs 2.31±1.08 mg/L ,P>0.05). No significant correlation was found between CETP concentration and lipids and lipoproteins concentration(P>0.05). Conclusions There is no significant relation between serum CETP level and CHD in Han nationality from northern China.
出处 《中国动脉硬化杂志》 CAS CSCD 2002年第5期442-444,共3页 Chinese Journal of Arteriosclerosis
关键词 中国北方地区 汉族人 冠心病 血清胆固醇酯转运蛋白 Cholesteryl Ester Transfer Protein Lipoprotein, HDL, Cholesterol Atherosclerosis Coronary Heart Disease
  • 相关文献

参考文献2

二级参考文献5

共引文献16

同被引文献33

  • 1[2]Rothblat GH, Llera-Moya M, Atger V, Weibel GK, Williams DL, Phillips MC. Cell cholesterol efflux;integration of old and new observations provides new insight. J Lipid Res, 1999, 40 (4): 781-796
  • 2[3]Bagdade JD, Wagner JD, Rudel LL, Clarkson TB. Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys. J Lipid Res, 1995, 36 (4): 759-766
  • 3[4]Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem, 1998, 273: 5 033-036
  • 4[5]Rittershaus CW, Miller DP, Thomas LJ, Picard MD, Honan CM, Emmett CD. Vaccine- induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol, 2000, 20: 2 106-112
  • 5[6]Grooth GJ, Kuivenhoven JA, Stalenhoef AF, Graaf J, Zwinderman AH,Posma JL. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation, 2002, 105 (18): 2 159-165
  • 6[7]Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol, 2001, 21 (2): 282-288
  • 7[8]Kawasaki I, Tahara H, Emoto M, Shoji T, Nishizawa YK. Relationship between TaqⅠB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes, 2002, 51 (3): 871-874
  • 8[9]Meguro S, Takei I, Murata M, Hirose H, Takei N, Mitsuyoshi Y. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis, 2001, 156 (1): 151-156
  • 9[10]Kuivenhoven JA, Jukema JW, Zwinderman AH, De Knijff P, McPherson R,Bruschke AV. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med, 1998, 338 (2): 86-93
  • 10[12]Durlach A, Clavel C, Girard-Globa A, Durlach V. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab, 1999, 84 (10): 3 656-659

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部